Mutant p53 is a transcriptional co-factor that binds to G-rich regulatory regions of active genes and generates transcriptional plasticity
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms underlying mutant p53 (mutp53) "gain-of-function" (GOF) are still insufficiently understood, but there is evidence that mutp53 is a transcriptional regulator that is recruited by specialized transcription factors. Here we analyzed the binding sites of mutp53 and the epigenetic status of mutp53-regulated genes that had been identified by global expression profiling upon depletion of endogenous mutp53 (R273H) expression in U251 glioblastoma cells. We found that mutp53 preferentially and autonomously binds to G/C-rich DNA around transcription start sites (TSS) of many genes characterized by active chromatin marks (H3K4me3) and frequently associated with transcription-competent RNA polymerase II. Mutp53-bound regions overlap predominantly with CpG islands and are enriched in G4-motifs that are prone to form G-quadruplex structures. In line, mutp53 binds and stabilizes a well-characterized G-quadruplex structure in vitro. Hence, we assume that binding of mutp53 to G/C-rich DNA regions associated with a large set of cancer-relevant genes is an initial step in their regulation by mutp53. Using GAS1 and HTR2A as model genes, we show that mutp53 affects several parameters of active transcription. Finally, we discuss a dual mode model of mutp53 GOF, which includes both stochastic and deterministic components.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199 · cited 2×
“In tumors, p53 function is inactivated by mutations in the TP53 gene with a frequency varying between 5% and 50%, depending on tissue origin.(3) About 74% of TP53-mutated tumors harbor missense-point mutations that result in a high-level expression of mutant p53 (mutp53), which is usually localized in the nucleus.”
BackgroundThe first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132 · cited 4×
“In contrast to deterministic regulation of a defined set of target genes by classical transcription factors, data on the transcriptional regulation by mutp53 point toward a cell, and context-specific impact of mutp53 on transcription.(5) Therefore, mutp53-regulated candidate genes must be unambiguously validated in th…”
BackgroundInfluentialAlcantara Llaguno, S., Chen, J., Kwon, C.-H., Jackson, E. L., Li, Y., Burns, D. K., Alvarez-Buylla, A., & Parada, L. F. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.006 · Cited by 694
Transcriptional Regulation by P53
Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569
p53 and its mutants in tumor cell migration and invasion
Muller, P. A. J., Vousden, K. H., & Norman, J. C. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009059 · Cited by 463
Di Agostino, S., Strano, S., Emiliozzi, V., Zerbini, V., Mottolese, M., Sacchi, A., Blandino, G., & Piaggio, G. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.013 · Cited by 418 · cited 1×
“Second, several effects of mutp53 on transcription of target genes of the transcription factors NF-Y, VDR and NF-kB, seem to require specific stimuli, like DNA damage, vitamin D or TNF-α treatment, respectively.(13,14,55) The fact that 83% of mutp53-bound promoters in U251 cells carry H3K4me3 indicates an active chrom…”
BackgroundModulation of the Vitamin D3 Response by Cancer-Associated Mutant p53
Stambolsky, P., Tabach, Y., Fontemaggi, G., Weisz, L., Maor-Aloni, R., Sigfried, Z., Shiff, I., Kogan, I., Shay, M., Kalo, E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.025 · Cited by 245 · cited 1×
“Second, several effects of mutp53 on transcription of target genes of the transcription factors NF-Y, VDR and NF-kB, seem to require specific stimuli, like DNA damage, vitamin D or TNF-α treatment, respectively.(13,14,55) The fact that 83% of mutp53-bound promoters in U251 cells carry H3K4me3 indicates an active chrom…”
BackgroundMutant p53 Cooperates with ETS and Selectively Up-regulates Human MDR1 Not MRP1
Sampath, J., Sun, D., Kidd, V. J., Grenet, J., Gandhi, A., Shapiro, L. H., Wang, Q., Zambetti, G. P., & Schuetz, J. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103429200 · Cited by 244 · cited 1×
“, transcription factors that have been reported to interact with mutp53 and also bind to G/C-rich DNA motifs.(30,31) Both SP1 and ETS1 are located in the nuclei of U251 cells, where they are associated with chromatin (Fig.”
Background
Research works printed but not linked: 50
- 10.1038/sj.onc.1210312 · DOI
- 10.1101/cshperspect.a001107 · DOI · Paper page
- 10.1038/sj.onc.1202314 · DOI · Paper page
- Bossi G, 2006, Oncogene, 25, 304, 10.1038/sj.onc.1209026 · DOI · Paper page
- 10.1038/cdd.2010.94 · DOI
- 10.1038/nm0909-1010 · DOI · Paper page
- 10.1101/gad.1881609 · DOI
- 10.1016/j.cell.2009.01.039 · DOI · Paper page
- 10.1038/nsmb.1669 · DOI · Paper page
- 10.1016/j.cell.2011.12.017 · DOI · Paper page
- 10.1101/gad.181685.111 · DOI · Paper page
- 10.1093/nar/gki252 · DOI · Paper page
- 10.1074/jbc.M507038200 · DOI
- 10.1093/nar/gkn1085 · DOI · Paper page
- 10.1158/0008-5472.CAN-04-1145 · DOI · Paper page
- 10.1093/bioinformatics/btn542 · DOI
- 10.1186/gb-2009-10-2-r14 · DOI · Paper page
- 10.1093/nar/gkq1170 · DOI · Paper page
- 10.1016/0092-8674(84)90368-4 · DOI · Paper page
- 10.1021/ja902281d · DOI · Paper page
- 10.1074/jbc.271.41.25468 · DOI · Paper page
- 10.1093/nar/gkp026 · DOI · Paper page
- 10.1006/bbrc.2000.3965 · DOI
- 10.1186/1471-2105-11-179 · DOI
- 10.1093/nar/gkr882 · DOI · Paper page
- 10.1371/journal.pbio.1001046 · DOI · Paper page
- 10.1093/nar/gkr1012 · DOI · Paper page
- Ciccarelli C, 1990, Mol Cell Biol, 10, 1525, 10.1128/MCB.10.4.1525 · doi:10.1128/mcb.10.4.1525
- 10.1016/j.cell.2007.05.009 · DOI · Paper page
- 10.1016/j.cell.2007.05.042 · DOI · Paper page
- 10.1016/j.molcel.2009.10.019 · DOI · Paper page
- 10.1101/gad.1235904 · DOI · Paper page
- Frazier MW, 1998, Mol Cell Biol, 18, 3735, 10.1128/MCB.18.7.3735 · DOI · Paper page
- 10.1158/0008-5472.CAN-08-0810 · DOI · Paper page
- 10.1074/jbc.M109.094813 · DOI · Paper page
- Ohyama T. DNA conformation and transcription. Landes Bioscience, New York, NY, 2005. · doi:10.1007/0-387-29148-2
- 10.1038/nrd3428 · DOI · Paper page
- 10.1093/nar/gkl529 · DOI · Paper page
- 10.1038/sj.cdd.4401909 · DOI
- 10.1128/MCB.25.22.10097-10110.2005 · DOI · Paper page
- 10.1038/sj.onc.1207553 · DOI
- 10.1158/0008-5472.CAN-04-1568 · DOI · Paper page
- 10.1002/pros.20308 · DOI · Paper page
- 10.1073/pnas.0506230102 · DOI · Paper page
- 10.1186/1471-2407-6-276 · DOI · Paper page
- 10.1186/bcr1675 · DOI · Paper page
- 10.1158/0008-5472.CAN-06-2425 · DOI · Paper page
- 10.1158/0008-5472.CAN-09-3406 · DOI · Paper page
- 10.1084/jem.20100797 · DOI · Paper page
- 10.1093/biostatistics/kxj037 · DOI · Paper page
Cited by
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Muller, P. A. J., & Vousden, K. H. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.021 · Cited by 1,545
The p53 Pathway in Glioblastoma
Zhang, Y., Dube, C., Gibert, M., Cruickshanks, N., Wang, B., Coughlan, M., Yang, Y., Setiady, I., Deveau, C., Saoud, K., et al. (2018) · Cancers · doi:10.3390/cancers10090297 · Cited by 440
Ubertini, V, Norelli, G., D'Arcangelo, D., Gurtner, A., Cesareo, E., Baldari, S., Gentileschi, M. P., Piaggio, G., Nisticò, P., Soddu, S., et al. (2015) · Oncogene · doi:10.1038/onc.2014.191 · Cited by 75
Metadata
- Authors
- Quante, T., Otto, B., Brázdová, M., Kejnovská, I., Deppert, W., & Tolstonog, G. V.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2012-09
- Volume
- 11
- Issue
- 17
- Pages
- 3290-3303
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W2070062778
- Cited by
- 63
- References
- 9
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mutant p53 is a transcriptional co-factor that binds to G-rich regulatory regions of active genes and generates transcriptional plasticity. https://app.cochat.ai/papers/10.4161/cc.21646
- The paper
- Quante, T., Otto, B., Brázdová, M., Kejnovská, I., Deppert, W., & Tolstonog, G. V. (2012). Mutant p53 is a transcriptional co-factor that binds to G-rich regulatory regions of active genes and generates transcriptional plasticity. Cell Cycle. https://doi.org/10.4161/cc.21646
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.